PYRAZINAMIDE Labatec cpr 500 mg 100 pce
7680576990023
CH-57699
J04AK01
08.02.1.
1 / 3
google
Details
- Product number
- 5769901
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- pyrazinamidum 500 mg, carboxymethylamylum natricum A corresp. natrium max. 1.96 mg, cellulosum microcristallinum, copovidonum, calcii stearas, pro compresso.
Articles (1)
Pyrazinamide Labatec 500 mg, comprimés
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 88.50
Specialties list
Yes
Generic
No
SL addition date:
01/12/2014
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 57699
- Drug name
- Pyrazinamide Labatec, comprimés
- Galenic form
- TAB
- ATC Code
- J04AK01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/06/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 08.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PYRAZINAMIDE Labatec cpr 500 mg 100 pce
- Description (DE)
- PYRAZINAMID Labatec Tabl 500 mg 100 Stk
- Market launch
- 01/06/2007
- Narcotic (BTM)
- No